Replies to post #16985 on Marker Therapeutics Inc (MRKR)

[lasers]

$TPIV current trials are all for TPIV200 vaccine, the alpha Folate Receptor cancer site and NOT for the HER2/neu TPIV100.

Gale's failure is for their HER2/neu vaccine, NeuVax.

https://clinicaltrials.gov/ct2/show/NCT01479244?term=neuvax&rank=1